Ionis Pharmaceuticals (IONS) Cash from Operations (2009 - 2026)

Ionis Pharmaceuticals' Cash from Operations history runs 18 years deep, the most recent figure standing at 792819000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 425.83% year-over-year to 792819000.0; the TTM figure through Mar 2026 stood at 910627000.0 (down 81.48% YoY), while the FY2025 annual figure was 268583000.0, up 46.38% from the prior year.
• Cash from Operations was 792819000.0 for Q1 2026 at Ionis Pharmaceuticals, down from 137709000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 151338000.0 in Q2 2025 to a low of 792819000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 126131294.12 across 5 years, with a median of 116139000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations slumped 453.38% in 2024, then surged 226.24% in 2025.
• A 5-year view of Cash from Operations shows it stood at 200195000.0 in 2022, then soared by 116.42% to 32865000.0 in 2023, then plunged by 453.38% to 116139000.0 in 2024, then retreated by 18.57% to 137709000.0 in 2025, then slumped by 475.72% to 792819000.0 in 2026.
• The last three Cash from Operations figures came in at 792819000.0 (Q1 2026), 137709000.0 (Q4 2025), and 131437000.0 (Q3 2025), per Business Quant data.